GET DAILY SIGNALSUnilever PLC (UL) Could See +12% Gain Toward $74 Analyst Target
Key Takeaways
- The central target examined here is $74, derived from the most recently updated analyst price targets for the ADR, which cluster in the low- to mid-$70s.
- At the latest verified close of $66.00, reaching $74 would require an upside of roughly 12%.
- The analyst range is wide: recent ADR targets span from about $60 (Morgan Stanley's $60.10) to roughly $74–$75, reflecting genuine disagreement on valuation and growth.
- Strongest supports: accelerating emerging-market-led underlying sales growth, a raised full-year volume outlook, and a defensive, dividend-paying business profile.
- Biggest risks: weakness in developed markets, a soft reaction to strong results, and a valuation that leaves limited room for error.
- For more on this ticker, explore its Major News, Today's Price Move, Forecast, and Earnings pages.
- To spot opportunities and monitor changing trends across the market, explore Trending AI Robots.
Analyst Price Targets and Consensus View
The $74 central target is not a single firm's call; it is the rounded average of the most recently maintained ADR price targets. MarketWatch tracks five analyst ratings with an average target near $74.50 (a tight $74–$75 band), while TipRanks reports a consensus closer to $72.50. In October 2026, TD Cowen analyst Robert Moskow trimmed his target to $74 from $76. Together these recent figures average roughly $73–74, which rounds to the $74 figure used here. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how recent technical signals align with the analyst views.
There is meaningful dispersion behind that number. Broader aggregators tracking older or London-converted estimates show a wider range from about $60 to $75, with MarketBeat's 19-analyst average near $68. Morgan Stanley's $60.10 target sits at the cautious end, while Bernstein (Buy) and a handful of others sit in the mid-$70s. The overall rating mix is also divided, with more neutral and cautious ratings than the headline targets suggest. In short, analysts broadly agree that Unilever is improving, but they disagree on how much that improvement is worth.
Current Market Position and Path Toward the Target
At $66.00, Unilever's ADR sits roughly 12% below the $74 target — a substantial but not extreme move for a large-cap consumer staple. The stock has traded in a 52-week range of $54.75 to $74.98, meaning the target sits just beneath the recent high.
The path toward $74 would likely require two things: continued underlying sales growth, and a re-rating of the shares. Unilever reported 5.2% underlying sales growth in the third quarter of 2026, ahead of company-compiled consensus and driven by emerging markets, while raising its full-year volume outlook to at least 3%. Yet the stock fell about 3% on the news, as investors focused on declining volumes in developed markets. That reaction highlights the gap between improving fundamentals and investor confidence.
What Could Support a Move Toward the Target
Several factors support a higher stock price. Unilever's emerging-markets exposure — roughly 58% of sales — gives it a structural growth engine, with India alone accounting for about 11% of revenue. The company has raised its volume outlook and continues to invest behind premium brands in beauty and wellbeing, which now represent over half of sales. A forward dividend yield near 3.2% provides income support that can attract defensive capital in uncertain markets. Positive analyst revisions, such as Deutsche Bank's November 2026 target increase citing "deep transformation" and multiple growth levers, also point to improving sentiment.
What Could Prevent the Target From Being Reached
The principal obstacle is developed-market weakness. Declining volumes in North America and Europe — the regions that carry the highest valuation multiple — have repeatedly offset emerging-market strength. A normalized P/E (price-to-earnings ratio) in the high teens leaves limited room for error if growth disappoints. Competitive pressure from local and niche brands in key categories remains a structural challenge. Finally, the stock's negative reaction to an otherwise strong third-quarter report suggests that even good news may not be enough to drive the shares higher unless developed-market momentum turns.
Technical Levels and Market Structure
The $74–$75 area is a meaningful resistance zone, matching the 52-week high of $74.98 and the cluster of recent analyst targets. A sustained move through that zone would require fresh buying conviction. On the downside, the $65 area acted as recent support, with the stock's November 6 close of $66.00 testing that shelf. Below that, the broader 52-week structure points to the mid-$50s as a deeper floor. The long-term trend remains constructive, but the shares are effectively rangebound between the mid-$60s and the mid-$70s.
Time Horizon and What Investors Should Monitor
Analyst price targets typically reflect a roughly 12-month horizon, though individual firms vary and some targets cited here are updated quarterly. Investors should watch upcoming earnings and guidance, particularly any sign that developed-market volumes stabilize or return to growth; analyst revisions and target changes; currency effects, given Unilever's broad geographic mix; and any strategic updates on portfolio reshaping. The company's next earnings report and full-year volume guidance will be the most direct tests of whether the $74 path remains credible.
Final Assessment
Can Unilever reach $74? The target is grounded in recent analyst estimates that cluster in the low-to-mid $70s, and it requires a roughly 12% advance from $66.00 — substantial but within the stock's recent trading range. The case rests on accelerating emerging-market growth, a raised volume outlook, and a dependable dividend. The counter-case rests on developed-market declines, a modest valuation cushion, and a market that has so far refused to reward strong results. With targets spread from about $60 to $75, the outcome will likely hinge on whether Unilever can convert its emerging-market momentum into developed-market volume growth. No outcome is guaranteed.
Using Tickeron AI Tools for Research
In my own process, I turn to Tickeron’s AI Daily Buy/Sell Signals when evaluating names like this one. The tool scans thousands of stocks and ETFs in real time, layering AI-driven technical analysis on top of fundamental data to flag potential shifts. It helps me stay objective when weighing analyst targets against current price action and momentum, without replacing core research.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
UL's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for UL turned positive on October 09, 2026. Looking at past instances where UL's MACD turned positive, the stock continued to rise in 25 of 45 cases over the following month. The odds of a continued upward trend are 56%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 24 of 63 cases where UL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 38%.
UL moved above its 50-day moving average on October 14, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for UL crossed bullishly above the 50-day moving average on October 19, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 53%.
Following a +4.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where UL advanced for three days, in 142 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 47%.
The Aroon Indicator entered an Uptrend today. In 69 of 200 cases where UL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 34%.
Bearish Trend Analysis
The 10-day RSI Indicator for UL moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 13 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UL as a result. In 34 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 40%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 43%.
UL broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. UL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 48 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.776) is normal, around the industry mean (21.952). P/E Ratio (15.529) is within average values for comparable stocks, (16.026). UL's Projected Growth (PEG Ratio) (6.572) is very high in comparison to the industry average of (1.518). Dividend Yield (0.032) settles around the average of (0.032) among similar stocks. P/S Ratio (2.336) is also within normal values, averaging (1.902).
The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of fast moving consumer goods
Industry HouseholdPersonalCare
Advertisement